nivolumab,ipilimumab
bms
['/ipi', 'nivo']
focus is on high t stage and low n stage - not resectable initially but potentially resectable after therapy. patients here received nivo/ipi on day 1 and nivo on day 22 with chemoradiation then resection 6w later (after restaging) with pcr/mpr primary endpoint. #esmo22 
Director of Thoracic Oncology & Developmental Therapeutics @LombardiCancer, Associate Professor @Georgetown University #LCSM #HereWeGo #ITYSL He/Him